Will that be hollandaise with your egg, or a side of vaccine?

With so much warning of the HIN1 flu pandemic, why don’t governments and the pharma industry have enough vaccine in time for this flu season? As Dr Dennis Gross explains, for vaccines, the process defines the product. Change the process and you might lose clinical efficacy. The processes for vaccine production – even in 2009 – are fraught with sometimes more art than science.

Details

Editorial: Great minds think alike

One of the best outcomes of our ever-shrinking world is the opportunity to meet colleagues from other countries, to learn their best practices, share ‘war stories’ of failed attempts, and garner new ideas for solutions in our respective home countries. ISPOR held its annual meeting in Paris, France last week, with a focus on health technology assessment processes worldwide.

Details

‘You say HTA, I say CER’: international perspectives on evidence-based health policy

George Bernard Shaw once described America and England as two countries separated by a common language. Might this also hold true for comparative effectiveness research and health technology assessment? This article highlights several, recently available resources for anyone seeking to understand healthcare systems outside their own country.

Details